0001104659-23-051798 | 20-F | XBRL Viewer

evax_ShareBasedCompensationVestingPeriod

3 years

evax_ShareBasedCompensationVestingPeriod

3 years

evax_ShareBasedCompensationVestingPeriod

36 months

evax_IncreaseInRegisteredShareCapital

$ 114,402

Right-of-use Assets Increase (Decrease) From Translation

evax_IncreaseInRegisteredShareCapital

$ 2,298,594

evax_RightOfUseAssetsIncreaseDecreaseFromTranslation

$ (163,000)

Right-of-use Assets Increase (Decrease) From Translation

evax_RightOfUseAssetsIncreaseDecreaseFromTranslation

(131,000)

Cash Bonus

evax_CashBonus

789,000

Cash Bonus

evax_CashBonus

668,000

Increase (decrease) through transaction costs, liabilities arising from financing activities

evax_IncreaseDecreaseThroughTransactionCostsLiabilitiesArisingFromFinancingActivities

(1,117,000)

Increase (decrease) through transaction costs, liabilities arising from financing activities

evax_IncreaseDecreaseThroughTransactionCostsLiabilitiesArisingFromFinancingActivities

$ (1,117,000)

Disclosure Of Instruments With Potential Future Dilutive Effect Not Included In Calculation Of Diluted Earnings Per Share [Table Text Block]

evax_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTableTextBlock

Lease Liabilities Increase (Decrease) From Translation

evax_LeaseLiabilitiesIncreaseDecreaseFromTranslation

$ (151,000)

Lease Liabilities Increase (Decrease) From Translation

evax_LeaseLiabilitiesIncreaseDecreaseFromTranslation

$ (128,000)

Ifrs Debt Instrument, Term

evax_IfrsDebtInstrumentTerm

8 years

IFRS Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage

evax_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage

2.80%

Reduction In Share Based Compensation Expense, Change in Estimate

evax_ReductionInShareBasedCompensationExpenseChangeInEstimate

$ 400,000

Receipt (Payment) of Non Current Financial Assets

evax_ReceiptPaymentOfNonCurrentFinancialAssets

24,000

Receipt (Payment) of Non Current Financial Assets

evax_ReceiptPaymentOfNonCurrentFinancialAssets

30,000

Receipt (Payment) of Non Current Financial Assets

evax_ReceiptPaymentOfNonCurrentFinancialAssets

$ (209,000)

Issuance OF Additional Ordinary Share warrants

evax_IssuanceOfAdditionalOrdinaryShareWarrants

1,298,196

Number Of Warrants Issued During Period

evax_NumberOfWarrantsIssuedDuringPeriod

351,036

Share-based Payment Award, Fair Value Assumptions, Share Price

evax_ShareBasedPaymentAwardFairValueAssumptionsSharePrice

$ 2.10

Exercise Price Per Warrant

evax_ExercisePricePerWarrant

$ 1

Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate,

evax_ShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

3.66%

Disclosure Of Adjustments For Non-cash Items [Table Text Block]

evax_DisclosureOfAdjustmentsForNonCashItemsTableTextBlock


	Year Ended
	December 31,
	2022		2021		2020

	(USD in thousands)
Income taxes	$	(772)	$	(178)	$	(1,557)
Tax credit schemes accounted for as grants		(226)		(12)		(510)
Depreciation		571		344		105
Impairment		87		—		—
Interest income		(13)		—		—
Interest expense		798		159		30
Share-based compensation expenses		942		1,379		3,408
Acquisition of property, plant and equipment		—		(90)		—
Gain in change from fair value of warrant liability		(395)		—		—
Other adjustments: Other adjustments, primarily exchange rate adjustments		(1,315)		(1,061)		107
Total adjustments for non-cash items	$	(323)	$	541	$	1,583

evax_NumberOfEmployeesAndConsultants

63,000

evax_NumberOfEmployeesAndConsultants

61,000

evax_NumberOfEmployeesAndConsultants

35,000

evax_NumberOfEmployeesAndConsultants

63,000

evax_NumberOfEmployeesAndConsultants

61,000

License Agreement on Milestone Payment

evax_NumberOfEmployeesAndConsultants

35,000

evax_LicenseAgreementOnMilestonePayment

$ 35,000

Share-based Payment Award, Fair Value Assumptions, Expected Term

evax_ShareBasedPaymentAwardFairValueAssumptionsExpectedTerm

6 years 6 months

Share based compensation expense by function [table text block]

evax_ShareBasedCompensationExpenseByFunctionTableTextBlock


	Years Ended
	December 31,
	2022		2021		2020

	(USD in thousands)
Research and development expenses	$	760	$	1,051	$	1,496
General and administrative expenses		182		328		1,912
Total	$	942	$	1,379	$	3,408

Weightage For Private Scenario, Share Price, Share Options Granted

evax_WeightageForPrivateScenarioSharePriceShareOptionsGranted

40.00%

Private Scenario, Share Price, Share Options Granted

evax_PrivateScenarioSharePriceShareOptionsGranted

$ 8.89

License Agreement Payment, Approval of Product

evax_LicenseAgreementPaymentApprovalOfProduct

$ 250,000

Percentage of Research And Intellectual Property Licensing Costs Divided Between Parties

evax_PercentageOfResearchAndIntellectualPropertyLicensingCostsDividedBetweenParties

50.00%

Ifrs Initial Recognition Fair Value Measurement Liabilities

evax_IfrsInitialRecognitionFairValueMeasurementLiabilities

$ 1,007,000

Weightage For IPO Scenario, Share Price, Share Options Granted

evax_WeightageForIpoScenarioSharePriceShareOptionsGranted

60.00%

Number of Shares Authorised Additional Increase

evax_NumberOfSharesAuthorisedAdditionalIncrease

1,800,000

Initial Public Offering Scenario, Share Price, Share Options Granted

evax_InitialPublicOfferingScenarioSharePriceShareOptionsGranted

$ 11.00

Lack Of Marketability Discount, Share Options Granted

evax_LackOfMarketabilityDiscountShareOptionsGranted

10.00%

Ifrs Share-based Payment Arrangement, Accelerated Cost

evax_IfrsShareBasedPaymentArrangementAcceleratedCost

$ 800,000

Additional Accrued Payment on License related

evax_AdditionalAccruedPaymentOnLicenseRelated

$ 60,000

Receivables [Text Block]

evax_ReceivablesTextBlock

Note 14. Prepayments and other receivables


	December 31,
	2022		2021

	(USD in thousands)
VAT receivables	$	287	$	387
Prepayments		2,494		638
Other receivables		10		113
Total prepayments and other receivables	$	2,791	$	1,138

The increase in prepayments derives from upfront payments made in relation to planned clinical trials.

Disclosure Executive Management's And Board Of Director's Holding Of Shares [Table Text Block]

evax_DisclosureExecutiveManagementsAndBoardOfDirectorsHoldingOfSharesTableTextBlock


Number of ordinary shares owned	2022	2021	2020
Per Norlén	—	—	—
Bo Karmark	2,000	—	—
Jesper Nyegaard Nissen	—	—	—
Birgitte Rønø	—	—	—
Erik Deichmann Heegaard	—	—	—
Andreas Holm Mattsson	4,071,961	4,163,832	4,163,832
Niels Iversen Møller	—	4,292,604	4,292,604
Lars Aage Staal Wegner (former)	82,124	182,124	182,124
Executive Management in total	4,156,085	8,638,560	8,638,560


Number of ordinary shares owned	2022	2021	2020
Niels Iversen Møller	4,196,840	—	—
Roberto Prego	310,248	310,248	310,248
Thomas William Wylonis (former)	—	—	485,676
Lars Holtug	—	—	—
Marianne Søgaard	41,652	41,652	41,652
Steven Projan	27,288	27,288	27,288
Board of Directors in total	4,576,028	379,188	864,864

Number Executive Management Member Resigned

evax_NumberExecutiveManagementMemberResigned

Number Executive Management Member Resigned

evax_NumberExecutiveManagementMemberResigned

Disclosure Of Receivables [Table Text Block]

evax_DisclosureOfReceivablesTableTextBlock


	December 31,
	2022		2021

	(USD in thousands)
VAT receivables	$	287	$	387
Prepayments		2,494		638
Other receivables		10		113
Total prepayments and other receivables	$	2,791	$	1,138

Registered Capital

evax_RegisteredCapital

$ 24,139,413

License Agreement Milestone Payment, Additional Payment

evax_LicenseAgreementMilestonePaymentAdditionalPayment

$ 320,000

Changes In Warrant Liability Foreign Currency Translation

evax_ChangesInWarrantLiabilityForeignCurrencyTranslation

$ (39,000)

Loan Agreement, Number of Tranches

evax_LoanAgreementNumberOfTranches

Share options Granted, Vesting Period

evax_ShareOptionsGrantedVestingPeriod

3 years

Debt Instrument Term1

evax_DebtInstrumentTerm1

6 years

evax_IncreaseInSharesThroughIssuanceOfShares

745,380

evax_IncreaseInSharesThroughIssuanceOfShares

269,136

evax_IncreaseInSharesThroughIssuanceOfShares

3,000,000

evax_IncreaseInSharesThroughIssuanceOfShares

3,942,856

Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

evax_IncreaseInSharesThroughIssuanceOfShares

62,284

evax_ShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

85.00%

Capitalized Intangible Assets Included In Trade Payables

evax_CapitalizedIntangibleAssetsIncludedInTradePayables

$ 60,000

Issued Capital, After Exercise of Warrants

evax_IssuedCapitalAfterExerciseOfWarrants

$ 24,139,413

Non management employee benefits expense including share-based compensation

evax_NonManagementEmployeeBenefitsExpenseIncludingShareBasedCompensation

$ 7,622,000

Non management employee benefits expense including share-based compensation

evax_NonManagementEmployeeBenefitsExpenseIncludingShareBasedCompensation

7,250,000

Non management employee benefits expense including share-based compensation

evax_NonManagementEmployeeBenefitsExpenseIncludingShareBasedCompensation

4,620,000

Acquisition Of Property And Equipment Included In Trade Payables

evax_AcquisitionOfPropertyAndEquipmentIncludedInTradePayables

90,000

Increase Through Accumulated Interest Liabilities Arising From Financing Activities

evax_IncreaseThroughAccumulatedInterestLiabilitiesArisingFromFinancingActivities

176,000

Increase Through Accumulated Interest Liabilities Arising From Financing Activities

evax_IncreaseThroughAccumulatedInterestLiabilitiesArisingFromFinancingActivities

524,000

Increase Through Accumulated Interest Liabilities Arising From Financing Activities

evax_IncreaseThroughAccumulatedInterestLiabilitiesArisingFromFinancingActivities

700,000

Increase Through Accumulated Interest Liabilities Arising From Financing Activities

evax_IncreaseThroughAccumulatedInterestLiabilitiesArisingFromFinancingActivities

123,000

Increase Through Accumulated Interest Liabilities Arising From Financing Activities

evax_IncreaseThroughAccumulatedInterestLiabilitiesArisingFromFinancingActivities

31,000

Increase Through Accumulated Interest Liabilities Arising From Financing Activities

evax_IncreaseThroughAccumulatedInterestLiabilitiesArisingFromFinancingActivities

$ 154,000

Line Of Credit, Payment Term From Draw Date

evax_LineOfCreditPaymentTermFromDrawDate

6 years

Tax rate Effect Of Research And Development Tax Credit

evax_TaxRateEffectOfResearchAndDevelopmentTaxCredit

(5.00%)

Tax rate Effect Of Research And Development Tax Credit

evax_TaxRateEffectOfResearchAndDevelopmentTaxCredit

(4.00%)

Tax rate Effect Of Research And Development Tax Credit

evax_TaxRateEffectOfResearchAndDevelopmentTaxCredit

9.00%

Acquisition Of Property Plant And Equipment

evax_AcquisitionOfPropertyPlantAndEquipment

$ (90,000)

Additional Lease Liabilities

evax_AdditionalLeaseLiabilities

15,000

Additional Lease Liabilities

evax_AdditionalLeaseLiabilities

$ 2,731,000

Effective interest rate, monthly

evax_EffectiveInterestRateMonthly

0.78%

Weighted Average Remaining Contractual Life Of Share Options Cancelled During Period.

evax_WeightedAverageRemainingContractualLifeOfShareOptionsCancelledDuringPeriod.

15 years

Changes In Provision Table Text Block

evax_ChangesInProvisionTableTextBlock


	Provisions
	(USD in
	thousands)
Carrying amount at January 1, 2022	$	153
Provisions recognized		—
Additions		—
Utilization of provision		—
Change in the provision		—
Currency adjustment		(9)
Carrying amount at December 31, 2022	$	144


	Provisions
	(USD in
	thousands)
Carrying amount at January 1, 2021	$	—
Provisions recognized		161
Additions		—
Utilization of provision		—
Change in the provision		—
Currency adjustment		(8)
Carrying amount at December 31, 2021	$	153

Disclosure Of Cash And Cash Equivalents [Table Text Block]

evax_DisclosureOfCashAndCashEquivalentsTableTextBlock


	December 31,
	2022		2021

	(USD in thousands)
Cash and cash equivalents	$	13,184	$	32,166
Total cash and cash equivalents	$	13,184	$	32,166

Government Grants Receivables, Current

evax_GovernmentGrantsReceivablesCurrent

$ 221,000

Government Grants Receivables, Current

evax_GovernmentGrantsReceivablesCurrent

$ 563,000

Schedule of auditors' remuneration [table text block]

evax_ScheduleOfAuditorsRemunerationTableTextBlock


	December 31,
	2022		2021

	(USD in thousands)
Audit fees	$	172	$	177
Audit related fees		50		108
Other fees		156		328
Total fees	$	378	$	613

Provision Recognized

evax_ProvisionRecognized

$ 161,000

Share based compensation awards granted to key management personnel [table text block]

evax_ShareBasedCompensationAwardsGrantedToKeyManagementPersonnelTableTextBlock

The Board of Directors and Executive Management holding of share awards for the years ended December 31, 2020, 2021 and 2022 is shown below:


		Warrants held when				Warrants held when				Warrants held when
		becoming or leaving				becoming or leaving				becoming or leaving
	January 1,	as a member			December 31,	as a member			December 31,	as a member				December 31,
	2020	of management	Granted	Forfeited	2020	of management	Granted	Exercised	2021	of management	Granted	Exercised	Forfeited	2022
Thomas William Wylonis (former) ⁽¹⁾	342,612	(369,252)	26,640	—	—	369,252	—	—	369,252	—	—	(184,626)	—	184,626
Steven Projan	24,436	—	18,612	—	42,048	—	4,583	—	46,631	—	5,000	—	—	51,631
Roberto Prego	19,800	—	14,364	—	34,164	—	4,583	—	38,747	—	5,000	—	—	43,747
Jo Ann Suzich (former) ⁽⁷⁾	—	—	10,260	—	10,260	—	—	—	10,260	—	—	—	—	10,260
Marianne Søgaard ⁽²⁾	—	65,952	28,368	—	94,320	—	9,167	—	103,487	—	10,000	—	—	113,487
Helen Boudreau (former) ⁽³⁾	—	—	5,436	—	5,436	—	—	(5,436)	—	—	—	—	—	—
Kim Bjørnstrup (former) ⁽⁴⁾	—	5,868	5,868	—	5,868	—	—	—	5,868	—	—	—	—	5,868
Lars Holtug	—	—	—	—	—	—	4,583	—	4,583	—	5,000	—	—	9,583
Niels Iversen Møller	—	—	—	—	—	—	—	—	—	—	3,750	—	—	3,750
Board of Directors in Total	385,848	(309,168)	109,548	—	561,348	—	22,916	(5,436)	578,828	—	28,750	(184,626)	—	422,952
Lars Aage Staal Wegner	844,416	—	7,668	—	852,084	—	64,167	—	916,251	—	—	(62,736)	(45,327)	808,188
Birgitte Rønø	—	—	—	—	—	29,376	45,000	—	74,376	—	25,000	—	—	99,376
Thomas Bogenrieder (former) ⁽⁵⁾	49,572	(4,356)	—	(45,216)	4,356	—	—	—	4,356	—	—	—	—	4,356
Erik Heegaard	—	—	—	—	—	—	97,564	—	97,564	—	25,000	—	—	122,564
Glenn S. Vraniak (former) ⁽⁶⁾	150,660	—	—	—	150,660	—	—	—	150,660	—	—	(112,995)	—	37,665
Andreas Holm Mattsson	—	—	—	—	—	—	—	—	—	—	35,000	—	—	35,000
Bo Karmark	—	—	—	—	—	—	—	—	—	45,000	16,667	—	—	61,667
Jesper Nyegaard Nissen	—	—	—	—	—	—	—	—	—	25,000	20,833	—	—	45,883
Niels Iversen Møller ⁽⁸⁾	—	—	—	—	—	—	—	—	—	—	3,125	—	—	3,125
Per Norlén	—	—	—	—	—	—	—	—	—	50,000	3,125	—	—	53,125
Executive Management in total	1,044,648	(4,356)	—	(45,216)	1,007,100	29,376	206,731	—	1,243,207	120,000	128,750	(175,731)	(45,327)	1,270,899

(1)	Former board member until June 30, 2020, 252 warrants were granted for services provided after retirement from the Board of Director position.

(2)	As of November 25, 2020, 26,964 warrants were granted for services provided before taking on the Board of Directors position.

(3)	Former board member from June 30, 2020 to May 25, 2021.

(4)	Former board member from June 30, 2020 to November 4, 2020.

(5)	Part of Executive Management until March 31, 2020.

(6)	Mr. Vraniak resigned as the Chief Financial Officer of the Company effective November 1, 2021.

(7)	Board member until May 25, 2021.

(8)	Became a Board member in 2022.

Par Value Per Share, Prior to Stock Split

evax_ParValuePerSharePriorToStockSplit

$ 2

Acquisition of property and equipment through loan from lessor

evax_AcquisitionOfPropertyAndEquipmentThroughLoanFromLessor

$ 84,000

Borrowings from EIB Loan

evax_BorrowingsFromEibLoan

$ 6,932,000

Long-term Debt, Repayment Period

evax_LongTermDebtRepaymentPeriod

6 years

Government Grants Receivables, NonCurrent

evax_GovernmentGrantsReceivablesNoncurrent

$ 209,000

Disclosure Of Schedule Of Changes In Net Working Capital [Table Text Block]

evax_DisclosureOfScheduleOfChangesInNetWorkingCapitalTableTextBlock


	December 31,
	2022		2021		2020

	(USD in thousands)
Changes in receivables and tax receivables	$	(1,486)	$	1,863	$	(2,501)
Changes in trade payables		(599)		(647)		1,798
Changes in other payables		(792)		21		918
Changes in net working capital	$	(2,877)	$	1,237	$	215

Weighted average exercise price of share options granted in share-based payment arrangement, prior to stock split

evax_WeightedAverageExercisePriceOfShareOptionsGrantedInShareBasedPaymentArrangementPriorToStockSplit

$ 2

Increase In Number Of Warrants, Ratio

evax_IncreaseInNumberOfWarrantsRatio

Executive Management [Member]

Warrants Granted With Vesting Over The Next Three Years

evax_WarrantsGrantedWithVestingOverNextThreeYears

150,660

Warrants granted with immediate vesting

evax_WarrantsGrantedWithImmediateVesting

22,916

Warrants granted with immediate vesting

evax_WarrantsGrantedWithImmediateVesting

2,500

evax_ShareBasedCompensationVestingPeriod

3 years

IFRS Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

evax_ShareBasedCompensationVestingPeriod

36 months

CFO [Member]

evax_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod

36 months

COO [Member]

IFRS Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

evax_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod

36 months

Chief Executive Officer [Member]

IFRS Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

evax_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod

36 months

Employees [Member]

Warrants Granted With Vesting Over The Next Three Years

evax_WarrantsGrantedWithVestingOverNextThreeYears

7,956

Warrants granted with immediate vesting

evax_WarrantsGrantedWithImmediateVesting

54,000

Chief Medical Officer [Member]

IFRS Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

evax_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod

36 months

Share Warrants Exercise, Tranche Two [Member]

evax_NumberOfSharesIssuedExerciseOfWarrants

37,665

Share Warrants Exercise, Tranche One [Member]

evax_NumberOfSharesIssuedExerciseOfWarrants

41,085

evax_NumberOfSharesIssuedExerciseOfWarrants

92,313

Share Warrants Exercise, Tranche Three [Member]

evax_NumberOfSharesIssuedExerciseOfWarrants

92,313

Grant December 2016 [Member]

evax_NumberOfSharesIssuedExerciseOfWarrants

17,264

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

$ 20.91

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

20.91

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

20.91

Grant September 2022 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

10.46

Grant December 2022 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

10.95

Grant December 2020 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

56.75

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

56.75

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

56.75

Grant September 2019 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

56.35

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

56.35

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

56.35

Grant June 2022, Third [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

8.85

Grant June 2022, Second [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

8.85

Granted during 2018 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

37.05

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

37.05

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

37.05

Grant December 2022, First [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

10.95

Grant February 2019 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

42.57

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

42.57

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

$ 42.57

Grant December 2022, Second [Member]

Share Based Awards Remaining Term to Maturity

evax_ShareBasedAwardsRemainingTermToMaturity

9 years

Grant December 2017 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

$ 28.71

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

28.71

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

28.71

Grant March 2022 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

13.46

Grant April 2021 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

45.31

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

45.31

Grant June 2022, First [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

8.85

Grant June 2021 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

40.86

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

40.86

Grant September 2017 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

28.71

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

28.71

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

28.71

Grant April 2017 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

24.05

Grant October 2019 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

56.97

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

56.97

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

56.97

Grant December 2021 [Member]

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

19.22

Weighted Average Grant Date Fair Value Of Share Options Granted In Share-based Payment Arrangement, Per Share

evax_WeightedAverageGrantDateFairValueOfShareOptionsGrantedInShareBasedPaymentArrangementPerShare

$ 19.22

Warrants [Member]

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount1

evax_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1

2,743,093

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount1

evax_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1

2,732,618

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount1

evax_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1

2,228,076

At-The-Market Issuance Sales Agreement

evax_IncreaseInRegisteredShareCapital

$ 4,450

Entity Listing, Depository Receipt Ratio

evax_IncreaseInRegisteredShareCapital

$ 114,403

dei_EntityListingDepositoryReceiptRatio

Entity Listing, Depository Receipt Ratio

dei_EntityListingDepositoryReceiptRatio

Entity Listing, Depository Receipt Ratio

dei_EntityListingDepositoryReceiptRatio

Lincoln Park Purchase Agreement [Member]

Shares Sell Agreement, Number Sold At Reporting Date

evax_SharesSellAgreementNumberSoldAtReportingDate

428,572

Purchase Agreement To Sell Shares, Shares In Single Transaction

evax_PurchaseAgreementToSellSharesSharesInSingleTransaction

50,000

Number of Shares Registered for Resale

evax_NumberOfSharesRegisteredForResale

4,649,250

Purchase Agreement To Sell Shares, Maximum Shares In Single Transaction

evax_PurchaseAgreementToSellSharesMaximumSharesInSingleTransaction

70,000

Agreement Term

evax_AgreementTerm

36 months

Amount of Proceeds to be Received under Agreement

evax_AmountOfProceedsToBeReceivedUnderAgreement

$ 40,000,000.0

New York, United States

Lease Term

evax_LeaseTerm

13 months

Hrsholm, Denmark

Lease Term

evax_LeaseTerm

10 years

Percentage OF Increase In Annual Lease Payment

evax_PercentageOfIncreaseInAnnualLeasePayment

2.00%

Percentage OF Increase In Annual Lease Payment

evax_PercentageOfIncreaseInAnnualLeasePayment

4.00%

Lease Monthly Payment

evax_LeaseMonthlyPayment

$ 26,000

Lease Monthly Payment

evax_LeaseMonthlyPayment

11,000

Lease Monthly Payment

evax_LeaseMonthlyPayment

15,000

Lease termination Fee

evax_LeaseTerminationFee

$ 2,700,000

Lease Space

evax_LeaseSpace

1,356

Lease Space

evax_LeaseSpace

839

Lease Space

evax_LeaseSpace

518

Copenhagen, Denmark

Number Of Leases

evax_NumberOfLeases

Research And Development Expenses [Member]

evax_EmployeeBenefitsAndShareBasedCompensations

$ 8,156,000

evax_EmployeeBenefitsAndShareBasedCompensations

7,845,000

Non management employee benefits expense including share-based compensation

evax_EmployeeBenefitsAndShareBasedCompensations

4,833,000

evax_NonManagementEmployeeBenefitsExpenseIncludingShareBasedCompensation

6,639,000

Non management employee benefits expense including share-based compensation

evax_NonManagementEmployeeBenefitsExpenseIncludingShareBasedCompensation

6,414,000

Non management employee benefits expense including share-based compensation

evax_NonManagementEmployeeBenefitsExpenseIncludingShareBasedCompensation

4,009,000

General And Administrative Expenses [Member]

evax_EmployeeBenefitsAndShareBasedCompensations

2,165,000

evax_EmployeeBenefitsAndShareBasedCompensations

2,152,000